Intrinsic Value

Cytek Biosciences, Inc. (CTKB)

$6.63

+0.34 (+5.41%)

Enterprise Value -964.96
Net Debt -134.46
Equity Value -830.50
Shares Outstanding 135.28
Equity Value Per Share -6.14



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt